2 healthcare ASX shares that Morgans loves right now

COVID-19, Delta, Omicron… Health is the topic du jour. Here's a pair of stocks that are set to take advantage.

| More on:

Should you invest $1,000 in Homeco Daily Needs Reit right now?

Before you buy Homeco Daily Needs Reit shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Homeco Daily Needs Reit wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 3 April 2025

doctor and nurse smiling in a hospital ward representing rising share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Health is a topic that's never been far from everyone's minds in the past 18 months, so it's worth looking at ASX shares that are contributing to our wellbeing.

Each month investment firm Morgans publishes its "best ideas", as analyst Andrew Tang explained.

"Our best ideas are those that we think offer the highest risk-adjusted returns over a 12-month timeframe supported by a higher-than-average level of confidence," he said in the December 'best ideas' memo.

"They are our most preferred sector exposures."

There are 2 healthcare ASX shares in Morgans' latest list that caught our eye:

Volatile short term but excellent long term

Breathing apparatus maker Resmed CDI (ASX: RMD) is a December buy for Morgans.

That's not to say the stock won't be up and down over the next year or so.

"The next few quarters will likely be volatile, as COVID-related demand for ventilators continues to slow and core sleep apnoea volumes gradually lift," said Tang.

"[But] nothing changes our medium/longer term view that the company remains well-placed as it builds a unique, patient-centric, connected-care digital platform that addresses the main pinch points across the healthcare value chain."

Medallion Financial managing director Michael Wayne agreed, telling The Motley Fool last week that Resmed shares are a "core position" that his clients are "comfortable" holding.

"They're growing at double digit revenue growth and earnings growth. Margins are very, very strong."

Although it's pulled back about 10% from its September highs, Resmed shares have still gained more than 31% for the year to date.

No end in sight for COVID-19 tests

International pathology services provider Sonic Healthcare Limited (ASX: SHL) was one of the best-performing health ASX shares last month.

"After a poor start to the month, shares in ASX healthcare giant Sonic Healthcare finished the month 7% in the green," reported The Motley Fool's Zach Bristow.

"Robust demand for COVID-19 tests and vaccinations bumped the company's sales and earnings during the quarter."

With the Omicron emerging in recent days, Tang has no doubt this activity will continue to bring in revenue.

"We see COVID-19 testing continuing into the foreseeable future, with growth potential in COVID serology testing."

He added Sonic's international core business is "increasingly resilient". 

"Strong balance sheet — gearing 21.6x, $1.3 billion headroom — [opens] the door to acquisitions, contracts and JVs."

Sonic shares closed the week at $42.62, up almost 30% for the year.

Motley Fool contributor Tony Yoo owns shares of ResMed Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended ResMed Inc. and Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Portrait, confidence and team of doctors in the hospital standing after a consultation or surgery. Success, healthcare and group of professional medical workers in collaboration at a medicare clinic.
Healthcare Shares

Macquarie's top 3 ASX stock picks in the healthcare sector

Top broker has revealed 3 healthcare stocks with upside. 

Read more »

Two lab workers fist pump each other.
Healthcare Shares

3 of the best ASX 200 healthcare shares to bring your portfolio to life

These shares could be just what the investment doctor ordered according to analysts.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Share Gainers

Guess which ASX All Ords stock just rocketed 28% on a new commercial contract!

The ASX All Ords stock has grabbed plenty of investor interest on Tuesday.

Read more »

Five healthcare workers standing together and smiling.
Healthcare Shares

Is the CSL share price a buy? Here's a top broker's view

Is this stock a healthy opportunity? Let’s have a look.

Read more »

Man ecstatic after reading good news.
Healthcare Shares

Which ASX company has just secured FDA approval?

This stock just announced some big news.

Read more »

Health professional putting on gloves.
Healthcare Shares

How will Ansell shares navigate tariffs according to Macquarie?

The next two years could be a challenging period for the PPE company.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Guess which ASX 200 stock is surging 18% on big news

This stock is getting a lot of love from investors on Monday.

Read more »

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, holding a mobile phone in his hand while thinking about something.
Healthcare Shares

CSL shares are having a tough time recently. Are they a buy or a sell?

Is now a good time to jump in and buy this blue chip star?

Read more »